high ki-67 breast cancer prognosis

Release time ：Dec-18,2024

Breast cancers with high Ki-67 indices typically have a poorer prognosis, which is associated with a high level of tumor cell proliferation.

Ki-67, a nuclear protein, indicates the degree of cell proliferation. In the context of breast cancer, the Ki-67 index is frequently employed to gauge the tumor's growth velocity and aggressiveness. Generally, a Ki-67 index exceeding 14% is classified as high, suggesting rapid tumor growth and a higher malignancy grade. Patients with such breast cancers are often at an increased risk of relapse and may have a reduced survival span.

For individuals with high Ki-67 breast cancer, it is advised to vigilantly monitor disease progression and adhere to the therapeutic recommendations provided by their physicians. Regular follow-ups and assessments are essential for timely adjustments to the treatment regimen. Additionally, maintaining healthy lifestyle practices, including a balanced diet, moderate exercise, abstaining from smoking, and limiting alcohol consumption, can contribute to an enhanced quality of life. Compliance with medical directives regarding medication is crucial; self-adjustment of drug dosages or discontinuation without professional guidance is inadvisable. Any uncertainties should be promptly addressed by consulting with a qualified healthcare provider.